TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Ward, E. AU - Hao, Y. AU - Xu, J. AU - Murray, T. AU - Thun, M. J. PY - 2008 DA - 2008// TI - Cancer statistics, 2008 JO - CA: Cancer J Clin VL - 58 ID - Jemal2008 ER - TY - JOUR AU - Zarogoulidis, K. AU - Zarogoulidis, P. AU - Darwiche, K. AU - Boutsikou, E. AU - Machairiotis, N. AU - Tsakiridis, K. AU - Katsikogiannis, N. AU - Kougioumtzi, I. AU - Karapantzos, I. AU - Huang, H. AU - Spyratos, D. PY - 2013 DA - 2013// TI - Treatment of non-small cell lung cancer (NSCLC) JO - J Thorac Dis VL - 5 ID - Zarogoulidis2013 ER - TY - JOUR AU - Zhang, J. -. F. AU - Wei, F. AU - Wang, H. -. P. AU - Li, H. -. M. AU - Qiu, W. AU - Ren, P. -. K. AU - Chen, X. -. F. AU - Huang, Q. PY - 2010 DA - 2010// TI - Potent anti-tumor activity of telomerase-dependent and HSV-TK armed oncolytic adenovirus for non-small cell lung cancer in vitro and in vivo JO - J Exp Clin Cancer Res VL - 29 UR - https://doi.org/10.1186/1756-9966-29-52 DO - 10.1186/1756-9966-29-52 ID - Zhang2010 ER - TY - JOUR AU - Elankumaran, S. AU - Chavan, V. AU - Qiao, D. AU - Shobana, R. AU - Moorkanat, G. AU - Biswas, M. AU - Samal, S. K. PY - 2010 DA - 2010// TI - Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy JO - J Virol VL - 84 UR - https://doi.org/10.1128/JVI.01553-09 DO - 10.1128/JVI.01553-09 ID - Elankumaran2010 ER - TY - JOUR AU - Vigil, A. AU - Park, M. S. AU - Martinez, O. AU - Chua, M. A. AU - Xiao, S. AU - Cros, J. F. AU - Martinez-Sobrido, L. AU - Woo, S. L. AU - Garcia-Sastre, A. PY - 2007 DA - 2007// TI - Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-07-1025 DO - 10.1158/0008-5472.CAN-07-1025 ID - Vigil2007 ER - TY - JOUR AU - Csatary, L. K. AU - Gosztonyi, G. AU - Szeberenyi, J. AU - Fabian, Z. AU - Liszka, V. AU - Bodey, B. AU - Csatary, C. M. PY - 2004 DA - 2004// TI - MTH-68/H oncolytic viral treatment in human high-grade gliomas JO - J Neurooncol VL - 67 UR - https://doi.org/10.1023/B:NEON.0000021735.85511.05 DO - 10.1023/B:NEON.0000021735.85511.05 ID - Csatary2004 ER - TY - JOUR AU - Freeman, A. I. AU - Zakay-Rones, Z. AU - Gomori, J. M. AU - Linetsky, E. AU - Rasooly, L. AU - Greenbaum, E. AU - Rozenman-Yair, S. AU - Panet, A. AU - Libson, E. AU - Irving, C. S. AU - Galun, E. AU - Siegal, T. PY - 2006 DA - 2006// TI - Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme JO - Mol Ther: J Am Soc Gene Ther VL - 13 UR - https://doi.org/10.1016/j.ymthe.2005.08.016 DO - 10.1016/j.ymthe.2005.08.016 ID - Freeman2006 ER - TY - JOUR AU - Lorence, R. M. AU - Roberts, M. S. AU - O’Neil, J. D. AU - Groene, W. S. AU - Miller, J. A. AU - Mueller, S. N. AU - Bamat, M. K. PY - 2007 DA - 2007// TI - Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus JO - Curr Cancer Drug Targets VL - 7 UR - https://doi.org/10.2174/156800907780058853 DO - 10.2174/156800907780058853 ID - Lorence2007 ER - TY - JOUR AU - Hotte, S. J. AU - Lorence, R. M. AU - Hirte, H. W. AU - Polawski, S. R. AU - Bamat, M. K. AU - O’Neil, J. D. AU - Roberts, M. S. AU - Groene, W. S. AU - Major, P. P. PY - 2007 DA - 2007// TI - An optimized clinical regimen for the oncolytic virus PV701 JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-1817 DO - 10.1158/1078-0432.CCR-06-1817 ID - Hotte2007 ER - TY - JOUR AU - Millar, N. S. AU - Chambers, P. AU - Emmerson, P. T. PY - 1988 DA - 1988// TI - Nucleotide sequence of the fusion and haemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains JO - J Gen Virol VL - 69 UR - https://doi.org/10.1099/0022-1317-69-3-613 DO - 10.1099/0022-1317-69-3-613 ID - Millar1988 ER - TY - JOUR AU - Peeters, B. P. AU - de Leeuw, O. S. AU - Koch, G. AU - Gielkens, A. L. PY - 1999 DA - 1999// TI - Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence JO - J Virol VL - 73 ID - Peeters1999 ER - TY - JOUR AU - Collins, M. S. AU - Bashiruddin, J. B. AU - Alexander, D. J. PY - 1993 DA - 1993// TI - Deduced amino acid sequences at the fusion protein cleavage site of Newcastle disease viruses showing variation in antigenicity and pathogenicity JO - Arch Virol VL - 128 UR - https://doi.org/10.1007/BF01309446 DO - 10.1007/BF01309446 ID - Collins1993 ER - TY - JOUR AU - Toyoda, T. AU - Sakaguchi, T. AU - Imai, K. AU - Inocencio, N. M. AU - Gotoh, B. AU - Hamaguchi, M. AU - Nagai, Y. PY - 1987 DA - 1987// TI - Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus JO - Virology VL - 158 UR - https://doi.org/10.1016/0042-6822(87)90261-3 DO - 10.1016/0042-6822(87)90261-3 ID - Toyoda1987 ER - TY - JOUR AU - Fu, F. AU - Zhao, M. AU - Yang, Y. J. AU - Tong, G. Z. AU - Yang, B. F. AU - Song, C. AU - Li, X. PY - 2011 DA - 2011// TI - Antiproliferative effect of newcastle disease virus strain D90 on human lung cancer cell line A549 JO - Oncol Res VL - 19 UR - https://doi.org/10.3727/096504011X13079697132880 DO - 10.3727/096504011X13079697132880 ID - Fu2011 ER - TY - JOUR AU - Reck, M. AU - Heigener, D. F. AU - Mok, T. AU - Soria, J. C. AU - Rabe, K. F. PY - 2013 DA - 2013// TI - Management of non-small-cell lung cancer: recent developments JO - Lancet VL - 382 UR - https://doi.org/10.1016/S0140-6736(13)61502-0 DO - 10.1016/S0140-6736(13)61502-0 ID - Reck2013 ER - TY - JOUR AU - Prestwich, R. J. AU - Harrington, K. J. AU - Pandha, H. S. AU - Vile, R. G. AU - Melcher, A. A. AU - Errington, F. PY - 2008 DA - 2008// TI - Oncolytic viruses: a novel form of immunotherapy JO - Exp Rev Anticancer Ther VL - 8 UR - https://doi.org/10.1586/14737140.8.10.1581 DO - 10.1586/14737140.8.10.1581 ID - Prestwich2008 ER - TY - JOUR AU - Li, P. AU - Chen, C. H. AU - Li, S. AU - Givi, B. AU - Yu, Z. AU - Zamarin, D. AU - Palese, P. AU - Fong, Y. AU - Wong, R. J. PY - 2011 DA - 2011// TI - Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer JO - Head Neck VL - 33 UR - https://doi.org/10.1002/hed.21609 DO - 10.1002/hed.21609 ID - Li2011 ER - TY - JOUR AU - Zamarin, D. AU - Palese, P. PY - 2012 DA - 2012// TI - Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions JO - Future Microbiol VL - 7 UR - https://doi.org/10.2217/fmb.12.4 DO - 10.2217/fmb.12.4 ID - Zamarin2012 ER - TY - JOUR AU - Zhao, H. AU - Peeters, B. P. PY - 2003 DA - 2003// TI - Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication JO - J Gen Virol VL - 84 UR - https://doi.org/10.1099/vir.0.18884-0 DO - 10.1099/vir.0.18884-0 ID - Zhao2003 ER - TY - JOUR AU - Mansour, M. AU - Palese, P. AU - Zamarin, D. PY - 2011 DA - 2011// TI - Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells JO - J Virol VL - 85 UR - https://doi.org/10.1128/JVI.01537-10 DO - 10.1128/JVI.01537-10 ID - Mansour2011 ER - TY - JOUR AU - Lazar, I. AU - Yaacov, B. AU - Shiloach, T. AU - Eliahoo, E. AU - Kadouri, L. AU - Lotem, M. AU - Perlman, R. AU - Zakay-Rones, Z. AU - Panet, A. AU - Ben-Yehuda, D. PY - 2010 DA - 2010// TI - The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin JO - J Virol VL - 84 UR - https://doi.org/10.1128/JVI.00401-09 DO - 10.1128/JVI.00401-09 ID - Lazar2010 ER - TY - JOUR AU - Elankumaran, S. AU - Rockemann, D. AU - Samal, S. K. PY - 2006 DA - 2006// TI - Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death JO - J Virol VL - 80 UR - https://doi.org/10.1128/JVI.00241-06 DO - 10.1128/JVI.00241-06 ID - Elankumaran2006 ER - TY - JOUR AU - Altomonte, J. AU - Marozin, S. AU - Schmid, R. M. AU - Ebert, O. PY - 2010 DA - 2010// TI - Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma JO - Mol Ther VL - 18 UR - https://doi.org/10.1038/mt.2009.231 DO - 10.1038/mt.2009.231 ID - Altomonte2010 ER - TY - JOUR AU - Vigil, A. AU - Martinez, O. AU - Chua, M. A. AU - Garcia-Sastre, A. PY - 2008 DA - 2008// TI - Recombinant Newcastle disease virus as a vaccine vector for cancer therapy JO - Mol Ther: J Am Soc Gene Ther VL - 16 UR - https://doi.org/10.1038/mt.2008.181 DO - 10.1038/mt.2008.181 ID - Vigil2008 ER - TY - JOUR AU - Wei, D. AU - Sun, N. AU - Nan, G. AU - Wang, Y. AU - Liu, H. Q. AU - Peeters, B. AU - Chen, Z. N. AU - Bian, H. PY - 2012 DA - 2012// TI - Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors JO - Hum Gene Ther VL - 23 UR - https://doi.org/10.1089/hum.2011.207 DO - 10.1089/hum.2011.207 ID - Wei2012 ER - TY - JOUR AU - Elmore, S. PY - 2007 DA - 2007// TI - Apoptosis: a review of programmed cell death JO - Toxicol Pathol VL - 35 UR - https://doi.org/10.1080/01926230701320337 DO - 10.1080/01926230701320337 ID - Elmore2007 ER - TY - JOUR AU - Buchholz, U. J. AU - Finke, S. AU - Conzelmann, K. K. PY - 1999 DA - 1999// TI - Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter JO - J Virol VL - 73 ID - Buchholz1999 ER - TY - JOUR AU - Chai, Z. AU - Ma, W. AU - Fu, F. AU - Lang, Y. AU - Wang, W. AU - Tong, G. AU - Liu, Q. AU - Cai, X. AU - Li, X. PY - 2013 DA - 2013// TI - A SYBR Green-based real-time RT-PCR assay for simple and rapid detection and differentiation of highly pathogenic and classical type 2 porcine reproductive and respiratory syndrome virus circulating in China JO - Archs Virol VL - 158 UR - https://doi.org/10.1007/s00705-012-1504-7 DO - 10.1007/s00705-012-1504-7 ID - Chai2013 ER - TY - JOUR AU - Peeters, B. P. AU - Gruijthuijsen, Y. K. AU - de Leeuw, O. S. AU - Gielkens, A. L. PY - 2000 DA - 2000// TI - Genome replication of Newcastle disease virus: involvement of the rule-of-six JO - Arch Virol VL - 145 UR - https://doi.org/10.1007/s007050070059 DO - 10.1007/s007050070059 ID - Peeters2000 ER - TY - JOUR AU - Phillips, R. J. AU - Samson, A. C. AU - Emmerson, P. T. PY - 1998 DA - 1998// TI - Nucleotide sequence of the 5′-terminus of Newcastle disease virus and assembly of the complete genomic sequence: agreement with the “rule of six” JO - Arch Virol VL - 143 UR - https://doi.org/10.1007/s007050050435 DO - 10.1007/s007050050435 ID - Phillips1998 ER - TY - JOUR AU - Wang, X. AU - Martindale, J. L. AU - Holbrook, N. J. PY - 2000 DA - 2000// TI - Requirement for ERK activation in cisplatin-induced apoptosis JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.M004583200 DO - 10.1074/jbc.M004583200 ID - Wang2000 ER -